Interleukin-6 and the IL-6 (-174) C/G polymorphism in breast pathologies and in HIV-infected patients

Archives of Medical Science

Volumn 6, Issue 6, 2010, Pages 860-865

  Jablonowska, Elzbieta ^a   Kolacinska, Agnieszka ^b   Kuydowicz, Jan ^a   Przybylowska, Karolina ^a   Jablonowski, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Breast diseases; HIV; Interleukin 6; Polymorphism

Indexed keywords

INTERLEUKIN 6;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST TUMOR; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 78751545876     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.19292     Document Type: Article

References (19)

1. Goedert JJ, Schairer C, McNeel TS, Hessol NA, Rabkin CS, Engels EA; HIV/AIDS Cancer Match Study. Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. Br J Cancer 2006; 95: 642-8.
2. Head JF, Elliott RL, McCoy JL. Evaluation of lymphocyte immunity in breast cancer patients. Breast Cancer Res Treat 1993; 26: 77-88.
3. Intra M, Gentilini O, Brenelli F, Chagas EM, Veronesi U, Sandri MT. Breast cancer among HIV-infected patients: The experience of the European Institute of Oncology. J Surg Oncol 2005; 91: 141-2.
4. Pantanowitz L, Dezube BJ. Breast cancer in women with HIV/AIDS. JAMA 2001; 285: 3090-1.
5. Pantanowitz L. Breast cancer and AIDS. J Natl Med Assoc 2001; 93: 40-1.
6. Anshu, Shivkumar VB, Gangane N, Sharma S. Metaplastic carcinoma of the breast in an HIV-positive patient: A case report. Acta Cytol 2005; 49: 204-6.
7. Lee YW, Hirani AA, Kyprianou N, Toborek M. Human immunodeficiency virus-1 Tat protein up-regulates interleukin-6 and interleukin-8 expression in human breast cancer cells. Inflamm Res 2005; 54: 380-9.
8. Asgeirsson KS, Olafsdottir K, Jonasson JG, Ogmundsdottir HM. The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer. Cytokine 1998; 10: 720-8.
9. Badache A, Hynes NE. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Cancer Res 2001; 61: 383-91.
10. Danforth DN Jr, Sgagias MK. Interleukin-1a and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res 1993; 53: 1538-45.
11. Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay JY. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer 2003; 88: 1721-6.
12. Bozcuk H, Uslu G, Samur M, et al. Tumour necrosis factor- , interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. Cytokine 2004; 27: 58-65.
13. Zhang GJ, Adachi I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 1999; 19: 1427-32.
14. Hefler LA, Grimm C, Lantzsch T, et al. Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women. Clin Cancer Res 2005, 11: 5718-21.
15. Balasubramanian SP, Azmy IA, Higham SE, et al. Interleukin gene polymorphisms and breast cancer: A case control study and systematic literature review. BMC Cancer 2006; 6: 188.
16. DeMichele A, Martin AM, Mick R, et al. Interleukin-6 -174 GC polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res 2003; 63: 8051-6.
17. González-Zuloeta Ladd AM, Arias Vásquez A, et al. Interleukin 6 G-174 C polymorphism and breast cancer risk. Eur J Epidemiol 2006; 21: 373-6.
18. Iacopetta B, Grieu F, Joseph D. The -174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype. Br J Cancer 2004; 90: 419-22.
19. Przybylowska K, Kluczna A, Zadrozny M, et al. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast Cancer Res Treat 2006; 95: 65-72.